报告题目：抗血小板药物的药物基因组学与个体化用药
报告人：谢红光教授，博士生导师，南京市第一医院中心实验室主任
报告时间：2014年6月13日上午9:30
报告地点：江宁校区药学楼310室
主办单位：澳门威斯人0168 临床药学系
报告地点：江宁校区药学楼310室
主办单位：澳门威斯人0168 临床药学系
报告人代表作：
1. Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW,Xie HG.Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor. PLoS One 2014; 9(1): e84985.
2. Li Y, Tang HL, Hu YF,Xie HG.The gain-of-function variant allele CYP2C19*17: A double-edged sword between thrombosis and bleeding in clopidogrel-treated patients. Journal of Thrombosis & Haemostasis 2012; 10(2):199-206.
3.Xie HG, Kim RB, Wood AJJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response.Annual Review of Pharmacology and Toxicology. 2001; 41: 815-50.
